Danone officially launched a 5,200 m² research and innovation center in Shanghai on Nov. 2, advancing its work on nutritional solutions for early life, healthy aging, and longevity.
A centerpiece of the complex is the 900 m² Danone OneBiome Lab, the group’s third such site following openings in Paris-Saclay and Singapore. Isabelle Esser, chief research, innovation, quality and food safety officer, noted that the unit uses bacterial DNA extraction and analysis to decode individual gut profiles influenced by age, diet, and lifestyle.
Alongside the laboratory, the hub incorporates a 700 m² pilot plant and a 300 m² science experience and consumer engagement space. This integrated footprint enables Danone to pair consumer feedback with sensory testing, prototyping, packaging design, and digital health tech development under one roof.
The technical work focuses on two ends of China’s demographic curve: infant nutrition and healthy longevity. In infant milk formula, researchers examine human breast milk composition among Chinese mothers to reformulate Danone’s Aptamil product lines to match natural gut flora development.
For older consumers, the Shanghai team is working on products under lines like Ganmai, a brand Danone rolled out with timed probiotic fibre powders aimed at immune and digestive maintenance. The company had previously established an exploratory research venture with Qingdao University three years ago to study microbiome changes across life stages.
“Some of the most important scientific areas on which we at Danone are investing are related to gut health and to biotics,”
Said Isabelle Esser, chief research, innovation, quality and food safety officer at Danone.
Source link
